Core Laboratories Q3 revenue slightly misses estimates on project delays 

By Reuters News


Overview

  • Oilfield services provider's Q3 revenue slightly missed analyst expectations, up 6% sequentially

  • Adjusted EPS for Q3 met consensus

  • Company repurchased 87,873 shares for $1.1 mln during the quarter


Outlook

  • Core Labs sees Q4 2026 revenue between $128.5 mln and $134.5 mln

  • Company expects Q4 2026 EPS of $0.12 to $0.20

  • Core Labs expects Q4 revenue to remain relatively flat sequentially due to Middle East disruptions


Result Drivers

  • INTERNATIONAL DEMAND - Co said increased demand across Europe-Africa, Asia-Pacific, Latin America and Middle East drove sequential revenue growth in Reservoir Description segment

  • US PRODUCT SALES - Co said Production Enhancement segment revenue growth was led by strong US product sales, benefiting from improved land completion activity and increased adoption of proprietary technologies

  • PROJECT DELAYS - Co said timing of diagnostic service activity in Gulf of America, with several large projects delayed, partially offset gains in Production Enhancement segment


Company press release:


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q3 Revenue

Slight Miss*

$132.10 mln

$132.14 mln (3 Analysts)

Q3 Adjusted EPS

Meet

$0.16

$0.16 (3 Analysts)

Q3 EPS

$0.12

*Applies to a deviation of less than 1%; not applicable for per-share numbers.


Analyst Coverage

  • The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 2 "strong buy" or "buy", no "hold" and 1 "sell" or "strong sell"

  • The average consensus recommendation for the business support services peer group is "buy."

  • Wall Street's median 12-month price target for Core Laboratories Inc. is $13.00, about 23.9% above its October 28 closing price of $10.49

  • The stock recently traded at 16 times the next 12-month earnings vs. a P/E of 16 three months ago


Reuters Recommended Reads

  • Oct 28 - Oilfield services firms lean on Middle East rebound but risks persist

  • Oct 27 - Baker Hughes Q3 net income down by a third on Chart deal costs despite revenue, adj EPS beat

  • Oct 27 - NOV Q3 revenue beats estimates on Middle East demand


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.